Pfizer/BioNTech say COVID-19 vaccine safe in children, evokes robust immune response
eMediNexus, 21 September 2021
remove_red_eye 488 Views
#Hospital Medicine #Infectious Diseases #Pathology and Lab Medicine #Pharmacist #Public Health #Pulmonary Medicine
Coronavirus Live Count Map India
remove_red_eye 488 Views
COVID-19 Vaccine Updates
Coronavirus Protocols
#Hospital Medicine #Infectious Diseases #Pathology and Lab Medicine #Pharmacist #Public Health #Pulmonary Medicine
Pfizer Inc and BioNTech SE have stated that their COVID-19 vaccine evoked a strong immune response in children aged 5 to 11 years. They further stated that they intend to seek authorization for use of the vaccine in this age group in the United States, Europe and other places as early as possible.It has been reported that the vaccine induced an immune response, in children 5 to 11 years of age, in Phase II/III clinical trial, which matched the response seen previously among 16-to-25 year olds. T...
Create Account
Login Now
To read the complete article ,
create a free account.
Sign Up
to instantly read 30000+ free Articles & 1000+ Case Studies
Already registered?
It is welcome if the vaccine is effective and safe